Clinical Trials Browser

Phase 2 × Medulloblastoma × Diphtheria-Tetanus Vaccine × Clear all

NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma